When traditional therapies fail to provide relief from pain caused by lumbar degenerative diseases, surgical approaches such as transforaminal lumbar interbody fusion (TLIF) may be used. TLIF can be performed using traditional open techniques (O-TLIF) or minimally invasive techniques (MI-TLIF). Although the clinical differences between O-TLIF and MI-TLIF have been evaluated extensively in meta-analyses, there remains a lack of established economic evidence. To address this gap, this analysis, conducted by DePuy Synthes and supported by EVERSANA’s Value & Evidence group (George Wright and Ankita Kambli), investigated the budget impact of MI-TLIF versus O-TLIF for single-level fusion from a European hospital perspective.
The study’s findings demonstrated that the clinical benefits of MI-TLIF also translated into economic savings. Despite having a higher initial surgical device cost, MI-TLIF resulted in overall cost savings driven by decreased hospital stays, fewer surgical trays requiring sterilization and a decreased number of transfusion units to treat patients.
Given that the incidence of lower back pain is predicted to increase with a rapidly aging population, this analysis will help policy and hospital decision-makers understand the budget impact of performing open and minimally invasive TLIF procedures at their hospitals.
Author
George Wright is a Manager, HEOR at EVERSANA and for the past 6 years has worked on numerous medical device projects to provide clients with the tools they need to engage and inform their…
Ankita joined the Value & Evidence group at EVERSANA after completing her MSc in Microbiology and Immunology at Western University. She has several years of experience in academic research, with specializations in evolutionary biology,…